MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0040140
Gimlet Pharmaceuticals Private Limited
Gimlet Pharmaceuticals Private Limited - manufacturing in Greater Noida West, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.27 Lakh
▲ 6% YoY
Net loss · FY 2025
₹8.92 Lakh
Net margin -34%
EBITDA · FY 2025
-₹8.92 Lakh
EBITDA margin -34%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Gimlet Pharmaceuticals Private Limited
Data last updated:
Gimlet Pharmaceuticals Private Limited is a private limited company based in Greater Noida West, Uttar Pradesh, India. It operates in the diversified operations segment of the manufacturing sector. It was incorporated on 24 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U36949UP2018PTC100615. Its GSTIN is 09AAHCG1663P1Z1 (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kumar Gaurav and Kunal Kishore.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. H – 1103 Tower H Aig Park Avenue Gc02 Gaur City – 1, Greater Noida West, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.27 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹8.92 Lakh (net margin -34%) and EBITDA of -₹8.92 Lakh (EBITDA margin -34%). Revenue has grown at a compounded annual rate (CAGR) of 40% over five years.
Gimlet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0040140).
Company details
CIN U36949UP2018PTC100615
Registration Number 100615
Incorporation Date 24 January 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0040140
Key People
Kumar Gaurav Director Kunal Kishore Director Recognitions & Rankings of Gimlet Pharmaceuticals
Contact details
Gimlet Pharmaceuticals Private Limited's registered office is in Greater Noida West, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressFlat No. H – 1103 Tower H Aig Park Avenue Gc02 Gaur City – 1, Greater Noida West, Uttar Pradesh, India – 201301
- IndustryManufacturing, Other, Manufacturing
To see the full contact details of Gimlet Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Gimlet Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Gimlet Pharmaceuticals Private Limited
FY 2025 filings availableGimlet Pharmaceuticals Private Limited reported revenue of ₹26.27 Lakh (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹26.27 Lakh ▲ 6%
Net loss · FY 2025
₹8.92 Lakh margin -34%
EBITDA · FY 2025
-₹8.92 Lakh margin -34%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▼ 134%
3 years · compounded
▼ 347%
5 years · compounded
▼ 85%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 6% growth in the latest year. EBITDA fell 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34% | ||||
| Net Profit Margin | -34% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gimlet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gimlet Pharmaceuticals Private Limited
Gimlet Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumar Gaurav | Director | 24 Jan 2018 | 8 Years 9 Months | Current |
| Kunal Kishore | Director | 24 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Gimlet Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Domingo Pharmaceuticals Private Limited | ₹26.35 Lakh (FY 2025) | 296.0% | Siliguri, West Bengal, India | |||
| Bantings Pharmaceuticals Private Limited | ₹26.32 Lakh (FY 2025) | -23.0% | Asansol, West Bengal, India | |||
| Sihaul Pharmaceuticals (OPC) Private Limited | ₹26.32 Lakh (FY 2024) | 0.0% | Delhi, India | |||
| MC Luna Pharmaceuticals Private Limited | ₹26.28 Lakh (FY 2025) | -19.0% | Cuttack Sadar, Odisha, India | |||
| Zollikon Pharmaceuticals Private Limited | ₹26.28 Lakh (FY 2024) | 148.0% | Beur, Anishabad, Bihar, India | |||
| Gimlet Pharmaceuticals Private Limitedthis company | ₹26.27 Lakh (FY 2025) | -₹8.92 Lakh | -34% | 6.0% | Greater Noida West, Uttar Pradesh, India | |
| Mastodon Pharmaceuticals Private Limited | ₹26.26 Lakh (FY 2023) | 184.0% | Patna, Bihar, India | |||
| Poullac Pharmaceuticals Private Limited | ₹26.25 Lakh (FY 2025) | -77.0% | Saharanpur, Uttar Pradesh, India | |||
| Smilen Pharmaceuticals Private Limited | ₹26.24 Lakh (FY 2025) | 164.0% | Dombivli, Maharashtra, India | |||
| Dr Horton Pharmaceuticals Private Limited | ₹26.23 Lakh (FY 2025) | -39.0% | Delhi, India | |||
| Blessclaudius Pharmaceuticals Private Limited | ₹26.17 Lakh (FY 2025) | Ambala, Haryana, India |
To see the full peer comparison of Gimlet Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gimlet Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gimlet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gimlet Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCG1663P1Z1 | Uttar Pradesh | Active | 06 Apr 2018 |
| 10AAHCG1663P1ZI | Bihar | Active | 05 Nov 2022 |
To see the full GST registrations and return filing status of Gimlet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gimlet Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Kumar Gaurav was appointed as Director on 24 Jan 2018.
AGM
Gimlet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gimlet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Kumar Gaurav was appointed as Director.
Appointed
Kunal Kishore was appointed as Director.
Incorporation
24 Jan 2018
Gimlet Pharmaceuticals Private Limited was registered on 24 Jan 2018 with Roc Uttar Pradesh Ii & aged 8 years 9 months as per MCA records.
Frequently asked questions
Gimlet Pharmaceuticals is an active private limited company based in Greater Noida West, Uttar Pradesh, India. The company works in other, within the manufacturing industry. It was incorporated on 24 January 2018 (8+ years old) and is registered under CIN U36949UP2018PTC100615.
Gimlet Pharmaceuticals has 2 current directors:
- Kumar Gaurav - Director
- Kunal Kishore - Director
The latest financial statements of Gimlet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Gimlet Pharmaceuticals is 09AAHCG1663P1Z1, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAHCG1663P1ZI (Bihar).
The CIN (Corporate Identification Number) of Gimlet Pharmaceuticals is U36949UP2018PTC100615. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gimlet Pharmaceuticals was incorporated on 24 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Gimlet Pharmaceuticals by revenue are Domingo Pharmaceuticals Private Limited, Bantings Pharmaceuticals Private Limited, Sihaul Pharmaceuticals (OPC) Private Limited, MC Luna Pharmaceuticals Private Limited, Zollikon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kumar Gaurav was appointed as Director on 24 Jan 2018. Kunal Kishore was appointed as Director on 24 Jan 2018.
Yes, Gimlet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0040140).
The registered office of Gimlet Pharmaceuticals is at Flat No. H – 1103 Tower H Aig Park Avenue Gc02 Gaur City – 1, Greater Noida West, Uttar Pradesh, India – 201301.
Gimlet Pharmaceuticals operates in the manufacturing industry, in the other segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages